Search

everythinglearnresearchcommunity

for

Search:↓

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

COVID-19 can cause skin problems.

COVID-19 infection may cause hair loss a few months after recovery.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

There is no link between hair loss and prostate enlargement.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Key genes and pathways improve wool quality in Zhexi Angora rabbits.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

Trichoscopy is a reliable method for diagnosing hair-pulling disorder.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Hinokiflavone may help treat cancers and other health issues.